Folate and Folate-PEG-PAMAM Dendrimers: Synthesis, Characterization, and Targeted Anticancer Drug Delivery Potential in Tumor Bearing Mice

被引:271
作者
Singh, Prateek [1 ]
Gupta, Umesh [1 ]
Asthana, Abhay [1 ]
Jain, Narendra K. [1 ]
机构
[1] Dr HS Gour Univ Sagar, Dept Pharmaceut Sci, Pharmaceut Res Lab, Sagar 470003, MP, India
关键词
D O I
10.1021/bc800125u
中图分类号
Q5 [生物化学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Ligand-mediated targeting of drugs especially in anticancer drug delivery is an effective approach. Dendrimers, due to unique surface topologies, can be a choice in this context. In the present study, PAMAM (polyamidoamine) dendrimers up to fourth generation were synthesized and characterized through infrared (IR), nuclear magnetic resonance (NMR), electrospray ionization (ESI) mass spectrometric, and transmission electron microscopic (TEM) techniques. Primary amines present on the dendritic surface were conjugated through folic acid and folic acid-PEG (poly(ethylene glycol))-NHS (N-hydroxysuccinimide) conjugates. Tumor in mice was induced through the use of KB cell culture. Prepared dendritic conjugates were evaluated for the anticancer drug delivery potential using 5-FU (5-fluorouracil) in tumor-bearing mice. Approximately 31% of 5-FU was loaded in folate-PEG-dendritic conjugates. Results indicated that folate-PEG-dendrimer conjugate was significantly safe and effective in tumor targeting compared to a non-PEGylated formulation. Tailoring of dendrimers via PEG-folic acid reduced hemolytic toxicity, which led to a sustained drug release pattern as well as highest accumulation in the tumor area.
引用
收藏
页码:2239 / 2252
页数:14
相关论文
共 50 条
[1]
Agarwal A, 2008, J PHARM PHARMACOL, V60, P1
[2]
Ligand based dendritic systems for tumor targeting [J].
Agarwal, Abhinav ;
Saraf, Surbhi ;
Asthana, Abhay ;
Gupta, Umesh ;
Gajbhiye, Virendra ;
Jain, Narendra K. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 350 (1-2) :3-13
[3]
Glycoconjugated peptide dendrimers-based nanoparticulate system for the delivery of chloroquine phosphate [J].
Agrawal, Payal ;
Gupta, Umesh ;
Jain, N. K. .
BIOMATERIALS, 2007, 28 (22) :3349-3359
[4]
PEGylated peptide dendrimeric carriers for the delivery of antimalarial drug chloroquine phosphate [J].
Bhadra, D ;
Bhadra, S ;
Jain, NK .
PHARMACEUTICAL RESEARCH, 2006, 23 (03) :623-633
[5]
Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting [J].
Bhadra, D ;
Yadav, AK ;
Bhadra, S ;
Jain, NK .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 295 (1-2) :221-233
[6]
A PEGylated dendritic nanoparticulate carrier of fluorouracil [J].
Bhadra, D ;
Bhadra, S ;
Jain, S ;
Jain, NK .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 257 (1-2) :111-124
[7]
BHADRA D, 2006, NANOTECHNOLOGY CANC, P523
[8]
Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers [J].
Bielinska, A ;
KukowskaLatallo, JF ;
Johnson, J ;
Tomalia, DA ;
Baker, JR .
NUCLEIC ACIDS RESEARCH, 1996, 24 (11) :2176-2182
[9]
Nanoparticle and targeted systems for cancer therapy [J].
Brannon-Peppas, L ;
Blanchette, JO .
ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (11) :1649-1659
[10]
Nanoparticles in cancer therapy and diagnosis [J].
Brigger, I ;
Dubernet, C ;
Couvreur, P .
ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (05) :631-651